- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
drkoop buys drDrew to reach teen market
drkoop buys drDrew to reach teen marketdrkoop.com has bought drDrew.com, a healthcare content Web site targeting the 14- to 24-year-old market, for 1.58 million shares in common stock and $150,000 cash. Through the acquisition, which brings
drkoop buys drDrew to reach teen market
drkoop.com has bought drDrew.com, a healthcare content Web site targeting the 14- to 24-year-old market, for 1.58 million shares in common stock and $150,000 cash. Through the acquisition, which brings drkoop's user base to some two million, drkoop hopes to drive additional licensing revenue and leverage this access to the teen/young adult audience. While drDrew.com will continue to operate as a separate site, the two sites will integrate some content. The acquisition was not a risky move for the beleaguered dot-com and drkoop will continue to evaluate acquiring "undervalued properties," said Ed Cespedes, president of drkoop.
- Search Again
- Return To HNN Homepage
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
